CVS says it won't carry Johnson & Johnson's Tylenol products in all of its stores, and Pfizer is the subject of breakup speculation according to some reports. Enis Taner, RiskReversal.com and Steve Cortes, Veracruz, discuss which drug stock is a better play.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT